{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:01:19Z","timestamp":1785189679640,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008091","name":"Golestan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.heliyon.2020.e04553","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T16:30:04Z","timestamp":1595867404000},"page":"e04553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The association between leptin and adiponectin, and metabolic syndrome components and serum levels of lipid peroxidation in bipolar disorder patients treated with lithium and valproic acid"],"prefix":"10.1016","volume":"6","author":[{"given":"Neda","family":"Dolab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Zaman","family":"Kamkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghi","family":"Amiriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jale","family":"Yuzugulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Marjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoljalal","family":"Marjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2020.e04553_bib1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2010.04.012","article-title":"Bipolar disorder and metabolic syndrome: an international perspective","volume":"126","author":"McIntyre","year":"2010","journal-title":"J.\u00a0Affect. Disord."},{"issue":"2","key":"10.1016\/j.heliyon.2020.e04553_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/0253-7176.101767","article-title":"Metabolic syndrome in bipolar disorders","volume":"34","author":"Grover","year":"2012","journal-title":"Indian J. Psychol. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e04553_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2012.12050620","article-title":"Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators","volume":"170","author":"Vancampfort","year":"2013","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.heliyon.2020.e04553_bib4","first-page":"96","article-title":"\u0130ki u\u00e7lu Bozuklukta Cinsiyetler Aras\u0131 genetik Farkl\u0131l\u0131k: Triptofan Hidroksilaz gen Polimorfizmi","volume":"47","author":"\u00d6zen","year":"2010","journal-title":"N\u00f6ropsikiyatri Ar\u015fivi"},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04553_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4088\/JCP.13r08634","article-title":"Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression","volume":"75","author":"McElroy","year":"2014","journal-title":"J.\u00a0Clin. Psychiatr."},{"issue":"8","key":"10.1016\/j.heliyon.2020.e04553_bib6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2165\/00023210-200822080-00004","article-title":"Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden","volume":"22","author":"Fagiolini","year":"2008","journal-title":"CNS Drugs"},{"issue":"Suppl 2","key":"10.1016\/j.heliyon.2020.e04553_bib7","first-page":"15","article-title":"Metabolic issues and cardiovascular disease in patients with psychiatric disorders","volume":"118","author":"Casey","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.heliyon.2020.e04553_bib8","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1016\/0002-9343(91)90281-2","article-title":"Oxidative stress: from basic research to clinical application","volume":"91","author":"Sies","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.heliyon.2020.e04553_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","article-title":"Oxidative stress markers in bipolar disorder: a meta-analysis","volume":"111","author":"Andreazza","year":"2008","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.heliyon.2020.e04553_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","volume":"11","author":"Ng","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.heliyon.2020.e04553_bib11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/obr.12064","article-title":"Adiponectin and lipoprotein metabolism","volume":"14","author":"Christou","year":"2013","journal-title":"Obes. Rev."},{"key":"10.1016\/j.heliyon.2020.e04553_bib12","doi-asserted-by":"crossref","first-page":"444=451","DOI":"10.1016\/j.tem.2014.06.001","article-title":"The multifaceted and controversial immune=metabolic actions of adiponection","volume":"25","author":"Esmaili","year":"2014","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.heliyon.2020.e04553_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2020.e04553_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000054950","article-title":"Serum leptin and cholesterol values in suicide attempters","volume":"45","author":"Atmaca","year":"2002","journal-title":"Neuropsychobiology"},{"issue":"Suppl I","key":"10.1016\/j.heliyon.2020.e04553_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1590\/0037-8682-0258-2013","article-title":"Chagas disease in the State of Amazonas: history, epidemiological evolution, risks of endemicity and future perspectives","volume":"48","author":"Barbosa","year":"2015","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.heliyon.2020.e04553_bib16","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1080\/00048670802534341","article-title":"Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls","volume":"43","author":"Elmslie","year":"2009","journal-title":"Aust. N. Z. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04553_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2007.08.018","article-title":"The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders","volume":"426","author":"Kurt","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2020.e04553_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/0146167206292749","article-title":"Learning what feelings to desire: socialization of ideal affect through Children\u2019s storybooks","volume":"33","author":"Tsai","year":"2007","journal-title":"Pers. Soc. Psychol. Bull."},{"key":"10.1016\/j.heliyon.2020.e04553_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1079\/PNS2003256","article-title":"Energy balance in obesity","volume":"62","author":"Webber","year":"2003","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.heliyon.2020.e04553_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2016.02.003","article-title":"Leptin in bipolar disorder: a systematic review and meta-analysis","volume":"35","author":"Fernandes","year":"2016","journal-title":"Eur. Psychiatr."},{"issue":"6","key":"10.1016\/j.heliyon.2020.e04553_bib21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.coph.2007.10.010","article-title":"The leptin hypothesis of depression: a potential link between mood disorders and obesity?","volume":"7","author":"Lu","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e04553_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1073\/pnas.0508901103","article-title":"A\u00a0potential novel antidepressant","volume":"103","author":"Lu","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.heliyon.2020.e04553_bib23","first-page":"561","article-title":"Obes\u0131ty , ad\u0131ponect\u0131n and vascular inflammatory d\u0131sease","volume":"14","author":"Ouch\u0131","year":"2003","journal-title":"Curr. Op\u0131n. L\u0131p\u0131dol."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2020.e04553_bib24","first-page":"9S","article-title":"Metabolic actions of adipocyte hormones: focus on adiponectin","volume":"14","author":"Ahima","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.heliyon.2020.e04553_bib25","doi-asserted-by":"crossref","first-page":"14361","DOI":"10.1523\/JNEUROSCI.3171-11.2011","article-title":"Metabol\u0131c dysfunct\u0131on assoc\u0131ated w\u0131th ad\u0131ponect\u0131n def\u0131c\u0131ency enhances ka\u0131n\u0131c ac\u0131d-\u0131nduced se\u0131zure sever\u0131ty","volume":"31","author":"Lee","year":"2011","journal-title":"J.\u00a0Neurosc\u0131."},{"key":"10.1016\/j.heliyon.2020.e04553_bib26","first-page":"289","article-title":"Increased levels of ad\u0131pok\u0131nes \u0131n b\u0131polar d\u0131sease","volume":"46","author":"Barbosa","year":"2012","journal-title":"J.\u00a0Psych\u0131atr. Res."},{"key":"10.1016\/j.heliyon.2020.e04553_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11373-008-9261-z","article-title":"Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond","volume":"15","author":"Lu","year":"2008","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.heliyon.2020.e04553_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpsychires.2015.10.008","article-title":"Modulation of triglyceride accumulation in adipocytes by psychopharmacological agents in vitro","volume":"72","author":"Loffler","year":"2016","journal-title":"J.\u00a0Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2020.e04553_bib29","first-page":"126","article-title":"Valproic Acid as a potentiator of metabolic syndrome in institutionalized residents on concomitant antipsychotics: fat chance, or slim to none?","volume":"40","author":"Zuo","year":"2015","journal-title":"P\u00a0T : Peer Rev. J Formul. Manag"},{"issue":"3","key":"10.1016\/j.heliyon.2020.e04553_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2012.12050620","article-title":"Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators","volume":"170","author":"Vancampfort","year":"2013","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.heliyon.2020.e04553_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bdi.12243","article-title":"Medical burden in bipolar disorder: findings from the clinical and health outcomes initiative in Comparative effectiveness for bipolar disorder study (bipolar CHOICE)","volume":"17","author":"Sylvia","year":"2015","journal-title":"Bipolar Disord."},{"issue":"6","key":"10.1016\/j.heliyon.2020.e04553_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067133","article-title":"Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries","volume":"8","author":"Laursen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2020.e04553_bib33","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1517\/14656560903064170","article-title":"Treatment-refractory bipolar disorder: Classification to aid in clinical management","volume":"10","author":"Gajwani","year":"2009","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.heliyon.2020.e04553_bib34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1517\/17425250902911455","article-title":"A\u00a0review of valproate in psychiatric practice","volume":"5","author":"Haddad","year":"2009","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.heliyon.2020.e04553_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/j.2051-5545.2009.tb00199.x","article-title":"Metabol\u0131c syndrome \u0131n people w\u0131th sch\u0131zophren\u0131a; A rev\u0131ew","volume":"8","author":"Hurt","year":"2009","journal-title":"World Psychiatr."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04553_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"issue":"5","key":"10.1016\/j.heliyon.2020.e04553_bib37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4088\/JCP.v65n0507","article-title":"Are mood disorders and obesity related? A review for the mental health professional","volume":"65","author":"McElroy","year":"2004","journal-title":"J.\u00a0Clin. Psychiatr."},{"key":"10.1016\/j.heliyon.2020.e04553_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4088\/JCP.7075su1c.03","article-title":"Obes\u0131ty \u0131n patients w\u0131th severe mental \u0131llness; Overv\u0131ew and management","volume":"70","author":"McElroy","year":"2009","journal-title":"J.\u00a0Clin. Psychiatr."},{"key":"10.1016\/j.heliyon.2020.e04553_bib39","series-title":"Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression Un\u0131polar D\u0131sorder Second","author":"Goodw\u0131n","year":"2007"},{"key":"10.1016\/j.heliyon.2020.e04553_bib40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-5618.2005.00234.x","article-title":"Metabolicsyndrome in bipolar disorder: findings from the bipolar disorder Centerfor pennsylvanians","volume":"7","author":"Fagiolini","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.heliyon.2020.e04553_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0165-0327(80)90031-2","article-title":"Lithium carbonate and weight gain","volume":"2","author":"Peselow","year":"1980","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04553_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1176\/appi.ajp.160.1.112","article-title":"Obesity as a correlate of outcome in patients with bipolar I disorder","volume":"160","author":"Fagiolini","year":"2003","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04553_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2008.01204.x","article-title":"Weight gain in bipolar disorder: pharmacological treatment as a contributing factor","volume":"118","author":"Torrent","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.heliyon.2020.e04553_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1399-5618.2010.00823.x","article-title":"Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine\/metabolic system and treatment outcome","volume":"12","author":"Kemp","year":"2010","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e04553_bib45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0269881105057515","article-title":"Lithium: a review of its metabolic adverse effects","volume":"20","author":"Livingstone","year":"2006","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.heliyon.2020.e04553_bib46","author":"First","year":"1998"},{"key":"10.1016\/j.heliyon.2020.e04553_bib47","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert Panel on Detection and Evaluation of High Blood Cholesterol in Adults: executive summary of the third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2020.e04553_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0009-8981(78)90081-5","article-title":"Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method","volume":"90","author":"Satoh","year":"1978","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.heliyon.2020.e04553_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"CanadianNetworkforMoodandAnxietyTreatments (CANMAT)andInternational Society for Bipolar Disorders (ISBD) guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.heliyon.2020.e04553_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40263-013-0039-0","article-title":"Potential mechanisms of action of lithium in bipolar disorder","volume":"27","author":"Malhi","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.heliyon.2020.e04553_bib51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.biopsych.2004.06.012","article-title":"Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder","volume":"56","author":"Friedman","year":"2004","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.heliyon.2020.e04553_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder","volume":"65","author":"Chiu","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.heliyon.2020.e04553_bib53","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylvanen","year":"2002","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.heliyon.2020.e04553_bib54","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.pnpbp.2010.06.029","article-title":"Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population","volume":"34","author":"Lee","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04553_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00048670802534341","article-title":"Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls","volume":"43","author":"Elmslie","year":"2009","journal-title":"Aust. N. Z. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e04553_bib56","first-page":"414e420","article-title":"Metabolic syndrome in Tunisian bipolar I patients","volume":"11","author":"Ezzaher","year":"2011","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.heliyon.2020.e04553_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2020.e04553_bib58","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/oby.2002.150","article-title":"Plasma adiponectin levels in overweight and obese Asians","volume":"10","author":"Yang","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.heliyon.2020.e04553_bib59","first-page":"E272","article-title":"Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1","volume":"275","author":"Chen","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.heliyon.2020.e04553_bib60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2014.02.005","article-title":"Lithium decreases plasma adiponectin levels in bipolar depression","volume":"564","author":"Soeiro-de-Souzaa","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2020.e04553_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpsychires.2015.12.003","article-title":"Adipokines, metabolic dysfunction and illness course in bipolar disorder","volume":"74","author":"Mansur","year":"2016","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.heliyon.2020.e04553_bib62","first-page":"65","article-title":"Better prognosis in overweight\/obese coronary heart disease patients with high plasma levels of leptin","volume":"89","author":"Simiti","year":"2016","journal-title":"Clujul Med."},{"key":"10.1016\/j.heliyon.2020.e04553_bib63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000067809","article-title":"Serum leptin and cholesterol levels in patients with bipolar disorder","volume":"46","author":"Atmaca","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.heliyon.2020.e04553_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3956(98)00032-6","article-title":"Elevated nocturnal profiles of serum leptin in patients with depression","volume":"32","author":"Antonijevic","year":"1998","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.heliyon.2020.e04553_bib65","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-2007-979885","article-title":"Plasma leptin in depressed patients and healthy controls","volume":"28","author":"Deuschle","year":"1996","journal-title":"Horm. Metab. Res."},{"issue":"11","key":"10.1016\/j.heliyon.2020.e04553_bib66","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1195-1155","article-title":"Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects","volume":"1","author":"Maffei","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2020.e04553_bib67","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/phrs.1999.0603","article-title":"The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children","volume":"41","author":"Cengiz","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2020.e04553_bib68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eplepsyres.2007.11.005","article-title":"Increased oxidative stress in epileptic children treated with valproic acid","volume":"78","author":"Verrotti","year":"2008","journal-title":"Epilepsy Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020313979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020313979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:51:09Z","timestamp":1776214269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844020313979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2405844020313979"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04553","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between leptin and adiponectin, and metabolic syndrome components and serum levels of lipid peroxidation in bipolar disorder patients treated with lithium and valproic acid","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e04553"}}